228 related articles for article (PubMed ID: 15997385)
21. Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis.
Salvarani C; Olivieri I; Pipitone N; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M;
Clin Exp Rheumatol; 2006; 24(1):70-8. PubMed ID: 16539822
[TBL] [Abstract][Full Text] [Related]
22. Refining drug safety in rheumatology.
Cush JJ; Dao KH
Rheum Dis Clin North Am; 2012 Nov; 38(4):xi-xiv. PubMed ID: 23137585
[TBL] [Abstract][Full Text] [Related]
23. [Personalized medicine in rheumatology].
Szekanecz Z
Orv Hetil; 2013 Mar; 154(13):483-96. PubMed ID: 23524232
[TBL] [Abstract][Full Text] [Related]
24. Rheumatologic rehabilitation: the great expectation for rheumatic patients.
Maddali Bongi S; Matucci Cerinic M
Reumatismo; 2012 Mar; 64(1):1-6. PubMed ID: 22472777
[No Abstract] [Full Text] [Related]
25. [RHEUMATOLOGY - TIME FOR CHANGES].
Balbir-Gurman A; Slobodin G
Harefuah; 2017 Jul; 156(7):408-410. PubMed ID: 28786266
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic strategies: Ways to remission].
Krüger K; Edelmann E
Z Rheumatol; 2015 Jun; 74(5):386-7. PubMed ID: 26085071
[No Abstract] [Full Text] [Related]
27. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
Yazici Y; Abramson SB
Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
[TBL] [Abstract][Full Text] [Related]
28. [Institute of Rheumatology and progress of antirheumatic therapy].
Sigidin IaA
Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950
[TBL] [Abstract][Full Text] [Related]
29. [Rheumatology on the move].
Dörner T; Siegenthaler W; Burmester GR
Dtsch Med Wochenschr; 2002 Sep; 127(37):1875. PubMed ID: 12226786
[No Abstract] [Full Text] [Related]
30. Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
Ruperto N; Martini A
Georgian Med News; 2008 Mar; (156):68-74. PubMed ID: 18403813
[TBL] [Abstract][Full Text] [Related]
31. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
Feely MG; O'Dell JR
Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
[TBL] [Abstract][Full Text] [Related]
32. [Glucocorticoid therapy in the course of time].
Kaiser H; Burmester GR; Buttgereit F
Z Rheumatol; 2005 Apr; 64(3):147-8. PubMed ID: 15868330
[No Abstract] [Full Text] [Related]
33. The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network.
Harrold LR; Reed GW; Harrington JT; Barr CJ; Saunders KC; Gibofsky A; Greenberg JD; John A; Devenport J; Kremer JM
BMC Musculoskelet Disord; 2014 Nov; 15():389. PubMed ID: 25416400
[TBL] [Abstract][Full Text] [Related]
34. The possible clinical application of pharmacogenetics in rheumatology.
Ferraccioli G
J Rheumatol; 2003 Dec; 30(12):2517-20. PubMed ID: 14719186
[No Abstract] [Full Text] [Related]
35. [Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].
Gómez Reino J; Loza E; Andreu JL; Balsa A; Batlle E; Cañete JD; Collantes Estévez E; Fernández Carballido C; Fernández Sueiro JL; García de Vicuña R; González-Álvaro I; González Fernández C; Juanola X; Linares LF; Marenco JL; Martín Mola E; Moreno Ramos M; Mulero Mendoza J; Muñoz Fernández S; Queiro R; Richi Alberti P; Sanz J; Tornero Molina J; Zarco Montejo P; Carmona L;
Reumatol Clin; 2011; 7(5):284-98. PubMed ID: 21925444
[TBL] [Abstract][Full Text] [Related]
36. Implementation of recommended non-pharmacotherapy in rheumatology practice: need for improvement.
van der Linden S; Boonen A; van Tubergen A; Vosse D; Dekker J; Dijkmans B; van der Horst-Bruinsma I; Kapinga T; van der Leeden M; van den Ende C; Hazes JM; Linssen A; Vliet Vlieland T
Clin Exp Rheumatol; 2016; 34(1 Suppl 95):S15-7. PubMed ID: 26316176
[No Abstract] [Full Text] [Related]
37. Rheumatology, past, present and future.
Joshi VR
J Assoc Physicians India; 2012 Jan; 60():21-4. PubMed ID: 22715542
[No Abstract] [Full Text] [Related]
38. Biosimilar monoclonal antibodies: preclinical and clinical development aspects.
Gonçalves J; Araújo F; Cutolo M; Fonseca JE
Clin Exp Rheumatol; 2016; 34(4):698-705. PubMed ID: 27383278
[TBL] [Abstract][Full Text] [Related]
39. DANBIO: a nationwide registry of biological therapies in Denmark.
Hetland ML
Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S205-7. PubMed ID: 16273809
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in pediatric rheumatology: January to March 2019.
Kumar Patra P; Zaffar Banday A; Singh S
Int J Rheum Dis; 2019 Jul; 22(7):1327-1330. PubMed ID: 31245911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
